Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL6055991 | 0.84 | LMNA (0.41) | ALDH1A1POLBKMT2AMEN1CYP2C19 | |
| Styrene SCHEMBL3758847 | 0.82 | ALDH1A1 (0.50) | ALDH1A1TDP1AKR1C3KMT2AMEN1 | |
| SCHEMBL14533808 | 0.80 | — | — | |
| SCHEMBL26620 | 0.80 | — | — | |
| Phthalic Acid SCHEMBL8517832 | 0.79 | ALDH1A1 (0.47) | ALDH1A1ALOX15POLBMAPTHDAC8 | |
| Phthalic Acid SCHEMBL27350994 | 0.79 | ALDH1A1 (0.61) | ALDH1A1ALOX15MAPTHDAC8TDP1 | |
| Ethylene SCHEMBL3936195 | 0.78 | TSHR (0.36) | ALDH1A1TDP1KMT2AMEN1CYP2C19 | |
| Phthalic Acid SCHEMBL10400552 | 0.77 | ALDH1A1 (0.58) | ALDH1A1ALOX15POLBMAPTHDAC8 | |
| Phthalic Acid SCHEMBL6065205 | 0.77 | ALDH1A1 (0.64) | ALDH1A1ALOX15POLBMAPTHDAC8 | |
| Phthalic Acid SCHEMBL9015687 | 0.76 | ALDH1A1 (0.70) | ALDH1A1ALOX15POLBMAPTHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2542223-B1 | COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF | HANMI SCIENCE CO LTD (KR) | 2015-09-23 | — | — | EP | claimed |
| US-20150086623-A1 | CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION INCLUDING TAMSULOSIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND ORAL FORMULATION INCLUDING THE SAME | SAMYANG BIOPHARMACEUTICALS CORPORATION (KR) | 2015-03-26 | — | — | US | claimed |
| US-20130052264-A1 | CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION INCLUDING TAMSULOSIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND ORAL FORMULATION INCLUDING THE SAME | SAMYANG BIOPHARMACEUTICALS CORPORATION (KR) | 2013-02-28 | — | — | US | claimed |
| EP-2542223-A2 | COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF | Hanmi Science Co., Ltd. (KR) | 2013-01-09 | — | — | EP | claimed |
| US-20120321709-A1 | COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF | HANMI SCIENCE CO LTD (KR) | 2012-12-20 | — | — | US | claimed |
| US-20120015032-A1 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | HANALL PHARMACEUTICAL COMPANY, LTD. (KR) | 2012-01-19 | — | — | US | claimed |
| WO-2011108826-A2 | COMPLEX FORMULATION FOR ORAL ADMINISTRATION COMPRISING PROBIOTIC FORMULATION AND 5-HT4 RECEPTOR AGONIST AND METHOD FOR THE PREPARATION THEREOF | HANMI HOLDINGS CO., LTD. (KR) | 2011-09-09 | — | — | WO | claimed |
| US-20110123612-A1 | PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER | HANALL BIOPHARMA CO., LTD (KR) | 2011-05-26 | — | — | US | claimed |
| US-20110117194-A1 | PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER | HANALL BIOPHARMA CO., LTD. (KR) | 2011-05-19 | — | — | US | claimed |
| US-20110111021-A1 | PHARMACEUTICAL PREPARATION | HANALL BIOPHARMA CO., LTD. (KR) | 2011-05-12 | — | — | US | claimed |
| EP-2255797-A2 | COMPOSITE PREPARATION | HanAll Biopharma Co., Ltd. (KR) | 2010-12-01 | — | — | EP | claimed |
| EP-2180891-A2 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | Hanall Pharmaceutical Co., Ltd. (KR) | 2010-05-05 | — | — | EP | claimed |
| US-20100047341-A1 | COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY | HANALL PHARMACEUTICAL CO., LTD. (KR) | 2010-02-25 | — | — | US | claimed |
| EP-2079451-A1 | COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY | Hanall Pharmaceutical Co., Ltd. (KR) | 2009-07-22 | — | — | EP | claimed |
| WO-2009022821-A2 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | HANALL PHARMACEUTICAL COMPANY. LTD (KR) | 2009-02-19 | — | — | WO | claimed |
| WO-2008044862-A1 | COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY | HANALL PHARMACEUTICAL CO., LTD. (KR) | 2008-04-17 | — | — | WO | claimed |
| EP-0241178-B1 | PHARMACEUTICAL COMPOSITION FOR TREATING PERIODONTAL DISEASES | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 1992-01-08 | — | — | EP | claimed |
| EP-0241179-B1 | PHARMACEUTICAL COMPOSITION FOR PERIODONTAL DISEASES | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 1991-11-13 | — | — | EP | claimed |
| US-4981693-A | Pharmaceutical composition for periodontal diseases | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 1991-01-01 | — | — | US | claimed |
| US-4933182-A | Pharmaceutical composition for treating periodontal | ROHTO PHARMACEUTICAL CO. LTD. (JP) | 1990-06-12 | — | — | US | claimed |